Artemis II toilet acts up again as astronauts speed toward the moon to break Apollo 13’s record

Artemis II is now more than halfway to the moon and is set to reach its lunar flyby Monday, traveling over 252,000 miles (400,000 km) on a nearly 10-day mission that ends with an April 10 Pacific splashdown — poised to set a human distance record beyond Apollo 13. The mission remains on track despite a recurring urine-toilet malfunction; crew are using backup urine collection bags while engineers suspect an ice blockage and report the toilet still accepts solid waste. Canada’s Jeremy Hansen is the first non-U.S. citizen headed to the moon, and the flight advances NASA’s plans for a sustained lunar program and a planned 2028 south-pole landing.

Analysis

A visible human-systems hiccup on a flagship crewed program creates outsized programmatic and procurement cascades: certification-driven rework, additional spares, and expanded test campaigns tend to be front-loaded and concentrated on a few subsystem suppliers. Historically, safety-driven design fixes add mid-single-digit to low-double-digit percent cost inflation on affected subsystems and can cascade into 3–12 month schedule slips for follow-on hardware delivery; that magnifies near-term revenue for suppliers while compressing OEM margin if they absorb rework.

The near-term winners are suppliers that can rapidly provide flight‑qualified valves, seals, and ECLSS components and primes that own the integration contract — they get both one‑off remediation work and follow‑on sustainment windows. Conversely, aerospace OEMs with program-management visibility issues face reputational, contractual‑penalty, and budget-reprioritization risk that can push optional contract tranches out the fiscal-year boundary, shifting award timing by quarters.

Catalysts to watch are (1) NASA contractor corrective action notices and cost-reimbursable change orders over the next 30–90 days, (2) formal root‑cause reports that could widen the scope of rework over 3–9 months, and (3) FY‑end budget language or Congressional hearings that reallocate sustainment funding. The largest tail risk is a safety finding that triggers broader human-rating reviews across the program, which would materially change award cadence into 2027–2028 and reprice contractor optionality.

Key Decisions for Investors

• Long LMT (Lockheed Martin) — buy 6–12 month calls or a call spread; thesis: capture increased integration and sustainment spend from human-rating corrective work. Target 12–20% upside; set a hard stop at 8–10% given defense budget and political risk.
• Long NOC (Northrop Grumman) vs short BA (Boeing) — 3–9 month pair trade. NOC likely to win incremental sustainment and avionics scope; BA carries program‑management overhangs. If executed as equal risk notional, expect asymmetric upside for NOC of ~15% vs 8–10% downside on BA in the horizon described.
• Tactical long MAXR (Maxar) — 6–12 month equity position to play incremental demand for lunar imaging/infra support contracts if NASA expands commercial payloads. Reward conditional on contract wins; stop-loss at 12% below entry given cadence sensitivity to award timing.
• Event trade: buy small-cap ECLSS/space-component suppliers on post‑investigation weakness (watch for 30–90 day supplier buyback/reorder announcements). These can reprice 25–40% on visible corrective-action orders but carry binary execution risk if awards do not materialize.